| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Joint pain | 4 | 1 | |
| Inflammation | 3 | 1 | |
| Ehlers-Danlos syndrome | 1 | 1 | |
| Hypermobility syndrome | 1 | 0 | |
| Osteoarthritis | 1 | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 3 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Joint pain | 4 | 1 | |
| Inflammation | 3 | 1 | |
| Ehlers-Danlos syndrome | 1 | 1 | |
| Hypermobility syndrome | 1 | 0 | |
| Osteoarthritis | 1 | 1 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 3 |